Reuters logo
BRIEF-Zynerba Pharmaceuticals announces initiation of FAB-c exploratory Phase 2 clinical trial
January 3, 2017 / 12:37 PM / 9 months ago

BRIEF-Zynerba Pharmaceuticals announces initiation of FAB-c exploratory Phase 2 clinical trial

Jan 3 (Reuters) - Zynerba Pharmaceuticals Inc :

* Zynerba Pharmaceuticals announces initiation of the fab-c exploratory phase 2 clinical trial of zyn002 cbd gel in patients with fragile x syndrome

* Zynerba Pharmaceuticals Inc- anticipate having top line results for fab-c trial late in first half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below